PAULETTE JOHNSON: Open Payments
NPI 1508308131 · WEST MEMPHIS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,367 in 139 payments from 40 companies in 2025. Trend: 2023 $3,775 · 2024 $2,834 · 2025 $3,367
Food & beverage: $3,336Education: $31
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $336 |
| E.R. Squibb & Sons, L.L.C. | 14 | $243 |
| Janssen Biotech, Inc. | 12 | $234 |
| Stemline Therapeutics Inc. | 3 | $213 |
| Regeneron Healthcare Solutions, Inc. | 4 | $208 |
| Gilead Sciences, Inc. | 8 | $185 |
| Daiichi Sankyo Inc. | 7 | $171 |
| Novartis Pharmaceuticals Corporation | 8 | $146 |
| Merck Sharp & Dohme LLC | 5 | $128 |
| Eisai Inc. | 6 | $109 |
Products named: Enhertu, Orserdu, LIBTAYO, OPDIVO, Trodelvy, KEYTRUDA, Lenvima, KISQALI.
Industry payments across AR — which companies pay providers there.
